Nouveau Life Pharmaceuticals Stock Performance
| NOUV Stock | USD 0.0002 0.00 0.00% |
On a scale of 0 to 100, Nouveau Life holds a performance score of 1. The company secures a Beta (Market Risk) of 2.95, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nouveau Life will likely underperform. Please check Nouveau Life's market risk adjusted performance, jensen alpha, as well as the relationship between the Jensen Alpha and day typical price , to make a quick decision on whether Nouveau Life's current price movements will revert.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Nouveau Life Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Nouveau Life showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Nouveau |
Nouveau Life Relative Risk vs. Return Landscape
If you would invest 0.03 in Nouveau Life Pharmaceuticals on January 31, 2024 and sell it today you would lose (0.01) from holding Nouveau Life Pharmaceuticals or give up 33.33% of portfolio value over 90 days. Nouveau Life Pharmaceuticals is currently generating 0.2688% in daily expected returns and assumes 14.9352% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Nouveau, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nouveau Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nouveau Life's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nouveau Life Pharmaceuticals, and traders can use it to determine the average amount a Nouveau Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.018
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NOUV | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 14.94 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.27 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Nouveau Life is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nouveau Life by adding it to a well-diversified portfolio.
Nouveau Life Fundamentals Growth
Nouveau Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Nouveau Life, and Nouveau Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nouveau Pink Sheet performance.
| Return On Equity | -2.2 | |||
| Return On Asset | -0.2 | |||
| Current Valuation | 722.68 K | |||
| Price To Earning | (0.01) X | |||
| Price To Book | 22.72 X | |||
| EBITDA | (163.87 K) | |||
| Cash And Equivalents | 1.1 K | |||
| Cash Flow From Operations | (22.91 K) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 1.33 M | |||
| Retained Earnings | (236 K) | |||
| Current Asset | 1 K | |||
| Current Liabilities | 146 K | |||
About Nouveau Life Performance
To evaluate Nouveau Life Pharmac Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Nouveau Life generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Nouveau Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Nouveau Life Pharmac market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Nouveau's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc. Nouveau Life is traded on OTC Exchange in the United States.Things to note about Nouveau Life Pharmac performance evaluation
Checking the ongoing alerts about Nouveau Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nouveau Life Pharmac help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nouveau Life Pharmac had very high historical volatility over the last 90 days | |
| Nouveau Life Pharmac has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (357.25 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Nouveau Life Pharmaceuticals currently holds about 1.1 K in cash with (22.91 K) of positive cash flow from operations. |
- Analyzing Nouveau Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nouveau Life's stock is overvalued or undervalued compared to its peers.
- Examining Nouveau Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nouveau Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nouveau Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nouveau Life's pink sheet. These opinions can provide insight into Nouveau Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nouveau Life Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Nouveau Pink Sheet analysis
When running Nouveau Life's price analysis, check to measure Nouveau Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nouveau Life is operating at the current time. Most of Nouveau Life's value examination focuses on studying past and present price action to predict the probability of Nouveau Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nouveau Life's price. Additionally, you may evaluate how the addition of Nouveau Life to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |